Akebia Therapeutics, Inc. Uncategorized Contracts & Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Packaging Validation Transfer Agreement, dated April 20, 2023, by and between the Company and Otsuka Pharmaceutical Co. Ltd
Akebia Therapeutics, Inc.
Biotechnology
NY
2023
Amendment No. 5
Akebia Therapeutics, Inc.
Biotechnology
2023
Amended and Restated
Akebia Therapeutics, Inc.
Biotechnology
2023
Open Market Sale AgreementSM, dated April 7, 2022, by and between Akebia Therapeutics, Inc. and Jefferies LLC
Akebia Therapeutics, Inc.
Biotechnology
NY
2022
First Amendment and
Akebia Therapeutics, Inc.
Biotechnology
NY
2022
Royalty Interest Acquisition Agreement, dated February 25, 2021, by and between the Company and HealthCare Royalty Partners IV, L.P
Akebia Therapeutics, Inc.
Biotechnology
DE
2021
Description of Registrants Securities
Akebia Therapeutics, Inc.
Biotechnology
2021
Offer Letter to David Spellman, dated as of June 13
Akebia Therapeutics, Inc.
Biotechnology
2020
Description of Registrants Securities
Akebia Therapeutics, Inc.
Biotechnology
2020
Letter Agreement by and between Panion & BF Biotech, Inc., the Company and Keryx Biopharmaceuticals, Inc. dated October 24, 2018
Akebia Therapeutics, Inc.
Biotechnology
NY
2019
Offer Letter to Rita Jain, dated April 28, 2017
Akebia Therapeutics, Inc.
Biotechnology
2018
Letter Agreement between Akebia Therapeutics, Inc. and Mitsubishi Tanabe Pharma Corporation, dated September 26, 2017
Akebia Therapeutics, Inc.
Biotechnology
2017
CONFIDENTIAL
Akebia Therapeutics, Inc.
Biotechnology
NY
2017
SEPARATIONAGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
2014
CONSULTINGAGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
OH
2014
AMENDMENT NUMBER TWO TO THE SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
AMENDMENT NUMBER ONE TO SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
DE
2014